These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24914816)

  • 21. Prevalence and molecular profiling of Epstein Barr virus (EBV) among healthy blood donors from different nationalities in Qatar.
    Smatti MK; Yassine HM; AbuOdeh R; AlMarawani A; Taleb SA; Althani AA; Nasrallah GK
    PLoS One; 2017; 12(12):e0189033. PubMed ID: 29228016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of Epstein-Barr virus antibodies in healthy children and adolescents in Vitória, State of Espírito Santo, Brazil.
    Figueira-Silva CM; Pereira FE
    Rev Soc Bras Med Trop; 2004; 37(5):409-12. PubMed ID: 15361959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroepidemiology of EBV and interpretation of the "isolated VCA IgG" pattern.
    De Paschale M; Agrappi C; Manco MT; Mirri P; Viganò EF; Clerici P
    J Med Virol; 2009 Feb; 81(2):325-31. PubMed ID: 19107979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-specific prevalence of Epstein-Barr virus infection among Minnesota children: effects of race/ethnicity and family environment.
    Condon LM; Cederberg LE; Rabinovitch MD; Liebo RV; Go JC; Delaney AS; Schmeling DO; Thomas W; Balfour HH
    Clin Infect Dis; 2014 Aug; 59(4):501-8. PubMed ID: 24820696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EBV VCA IgM and cytomegalovirus IgM dual positivity is a false positive finding related to age and hepatic involvement of primary Epstein-Barr virus infection in children.
    Sohn MJ; Cho JM; Moon JS; Ko JS; Yang HR
    Medicine (Baltimore); 2018 Sep; 97(38):e12380. PubMed ID: 30235701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered prevalence and reactivity of anti-Epstein-Barr virus antibodies in patients with multiple sclerosis.
    Wagner HJ; Hennig H; Jabs WJ; Siekhaus A; Wessel K; Wandinger KP
    Viral Immunol; 2000; 13(4):497-502. PubMed ID: 11192296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescence assays as the reference method.
    Corrales I; Giménez E; Navarro D
    Clin Vaccine Immunol; 2014 May; 21(5):684-8. PubMed ID: 24623623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seropositivity of Epstein-Barr virus in Eastern Anatolian Region of Turkey.
    Ozkan A; Kilic SS; Kalkan A; Ozden M; Demirdag K; Ozdarendeli A
    Asian Pac J Allergy Immunol; 2003 Mar; 21(1):49-53. PubMed ID: 12931751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based Study.
    Guo J; Cui Z; Zheng Y; Li X; Chen Y
    Pathol Oncol Res; 2020 Oct; 26(4):2185-2190. PubMed ID: 32222897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroprevalence of Epstein-Barr virus antibody among children in various age groups in Bangkok, Thailand.
    Pancharoen C; Mekmullica J; Chinratanapisit S; Bhattarakosol P; Thisyakorn U
    Asian Pac J Allergy Immunol; 2001 Jun; 19(2):135-7. PubMed ID: 11699720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
    Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroepidemiology of Epstein-Barr virus and cytomegalovirus among Israeli male young adults.
    Levine H; Balicer RD; Rozhavski V; Halperin T; Shreberk M; Davidovitch N; Huerta-Hartal M; Ankol OE
    Ann Epidemiol; 2012 Nov; 22(11):783-8. PubMed ID: 22831994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serological Evidence for the Association Between Epstein-Barr Virus Infection and Sjögren's Syndrome.
    Xuan J; Ji Z; Wang B; Zeng X; Chen R; He Y; Rao P; Wu P; Shi G
    Front Immunol; 2020; 11():590444. PubMed ID: 33193425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population.
    Grandjean Lapierre S; Vallières E; Rabaamad L; Labrecque M; Chartrand C; Renaud C
    J Clin Virol; 2016 Aug; 81():1-5. PubMed ID: 27258036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiological and Liver Biomarkers Profile of Epstein-Barr Virus Infection and Its Coinfection with Cytomegalovirus in Patients with Hematological Diseases.
    Ferrari de Freitas L; de Melo Silva J; Nogueira Barbosa A; Miranda Santos E; Pinheiro-Silva R; Soares Pontes G
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of Epstein-Barr virus serostatus in young people in England.
    Winter JR; Taylor GS; Thomas OG; Jackson C; Lewis JEA; Stagg HR
    BMC Infect Dis; 2019 Nov; 19(1):1007. PubMed ID: 31779585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
    Maylin S; Feghoul L; Salmona M; Herda A; Mercier-Delarue S; Simon F; Legoff J
    J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Features of Epstein-Barr virus reactivation after allogeneic hematopoietic cell transplantation in Korean children living in an area of high seroprevalence against Epstein-Barr virus.
    Han SB; Bae EY; Lee JW; Jang PS; Lee DG; Chung NG; Jeong DC; Cho B; Lee SJ; Kang JH; Kim HK
    Int J Hematol; 2014 Aug; 100(2):188-99. PubMed ID: 24981711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroepidemiological analysis and literature review of the prevalence of Epstein-Barr virus and herpesvirus infections in pediatric cases with non-Hodgkin lymphoma in Central Europe.
    Vaillant V; Reiter A; Zimmermann M; Wagner HJ
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27752. PubMed ID: 30977593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maintenance of serum immunoglobulin G antibodies to Epstein-Barr virus (EBV) nuclear antigen 2 in healthy individuals from different age groups in a Japanese population with a high childhood incidence of asymptomatic primary EBV infection.
    Harada S; Kamata Y; Ishii Y; Eda H; Kitamura R; Obayashi M; Ito S; Ban F; Kuranari J; Nakajima H; Kuze T; Hayashi M; Okabe N; Senpuku H; Miyasaka N; Nakamura Y; Kanegane H; Yanagi K
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):123-30. PubMed ID: 14715558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.